Alyeska Investment Group
ACH

Alyeska Investment Group’s Accendra Health ACH Stock Holding History

Alyeska Investment Group’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,185,516
Closed -$28.6M – 487
2022
Q3 		$28.6M Sell
1,185,516
-155,147
-12% -$4.78M 0.33% 99
2022
Q2 		$42.2M Buy
1,340,663
+875,351
+188% +$31.7M 0.48% 58
2022
Q1 		$20.5M Buy
+465,312
New +$20M 0.23% 144
2016
Q3 		– Sell
-523,258
Closed -$19.6M – 510
2016
Q2 		$19.6M Buy
+523,258
New +$19.7M 0.18% 190

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alyeska Investment Group's ACH Position: Q4 2022 in Review

Alyeska Investment Group sold out of Accendra Health (ACH) in Q4 2022, closing a stake of 1,185,516 shares — an estimated $28.6M sold.

Alyeska Investment Group first reported a position in ACH in Q2 2016 and held it in 4 quarters. The position peaked at $42.2M in Q2 2022. 219 funds tracked by Wall St. Rank hold ACH as of Q4 2022.

  • Alyeska Investment Group reported no remaining Accendra Health position as of Q4 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 1,185,516 Accendra Health shares in Q4 2022, an estimated $28.6M.
  • Alyeska Investment Group first reported a position in Accendra Health in Q2 2016 and held it in 4 quarters.
  • Alyeska Investment Group's Accendra Health position peaked at $42.2M in Q2 2022.
  • 219 funds tracked by Wall St. Rank held Accendra Health as of Q4 2022.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.